Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Evaluation of the Human Factor IX Gene Therapy Vector TAK-748 in Hemophilia: Results from Non-Clinical Studies in Factor IX Knockout Mice and Rhesus Monkeys

Markus Weiller, Helen Wang, Sogué Coulibaly, Maria Schuster, Hanspeter Rottensteiner, Kefeng Sun, Marinee K Chuah, Thierry Vandendriessche, Friedrich Scheiflinger, Werner Höllriegl

Blood (2019) 134 (Supplement_1): 4633.

https://doi.org/10.1182/blood-2019-124734

Published: 2019

Journal Articles

AAV8-Specific Immune Adsorption Column: A Treatment Option for Patients with Pre-Existing Anti-AAV8 Neutralizing Antibodies

Anita Kruzik, PhD, Roland Raim, PhD, Dirk Voelkel, PhD, Markus Weiller, PhD, Werner Hoellriegl, PhD, Friedrich Scheiflinger, Hanspeter Rottensteiner, Birgit M Reipert, PhD, Maurus de la Rosa

Blood (2019) 134 (Supplement_1): 5922.

https://doi.org/10.1182/blood-2019-126730

Published: 2019

Journal Articles

Influence of Obesity on Factor IX Expression after Gene Therapy in a Mouse Model of Hemophilia B

Sogué Coulibaly, Markus Weiller, Alexander Bauer, Johannes Lengler, Stefan Romeder-Finger, Alexandra Kopić, Karima Benamara, Paul Monahan, Hanspeter Rottensteiner, Friedrich Scheiflinger, PhD, Marietta Turecek, Werner Hoellriegl, MD

Blood (2017) 130 (Supplement 1): 4878.

https://doi.org/10.1182/blood.V130.Suppl_1.4878.4878

Published: 2017

Journal Articles

CD4 + T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice

Katharina N. Steinitz, Pauline M. van Helden, Brigitte Binder, David C. Wraith, Sabine Unterthurner, Corinna Hermann, Maria Schuster, Rafi U. Ahmad, Markus Weiller, Christian Lubich, Maurus de la Rosa, Hans Peter Schwarz, Birgit M. Reipert

Blood (2012) 119 (17): 4073–4082.

https://doi.org/10.1182/blood-2011-08-374645

Published: 2012

Includes: Supplemental data

Journal Articles

Preclinical Immunogenicity Assessment of Baxter‘s Longer-Acting FVIII Candidate BAX 855 Using Novel Preclinical Models,

Frank M Horling, PhD, Sandra Schwele, PhD, Christian Lubich, Rafi U Ahmad, PhD, Markus Weiller, PhD, Margit Spatzenegger, Hans Peter Schwarz, MD, Birgit M Reipert, PhD

Blood (2011) 118 (21): 3323.

https://doi.org/10.1182/blood.V118.21.3323.3323

Published: 2011

Journal Articles

Preclinical Immunogenicity Assessment of Baxter‘s Recombinant Factor VIIa,

Frank M Horling, PhD, Christine Lenk, Rafi Uddin Ahmad, PhD, Markus Weiller, PhD, Maria Schuster, DVM, Hans Peter Schwarz, MD, Birgit M Reipert, PhD

Blood (2011) 118 (21): 3327.

https://doi.org/10.1182/blood.V118.21.3327.3327

Published: 2011

Journal Articles

Deciphering of CD4 + T Cell Subsets Involved in Maintenance and Break of Immune Tolerance in a Humanized Mouse Model That Is Immune Tolerant to Human FVII

Christine Lenk, Markus Pasztorek, Markus Weiller, PhD, Rafi Uddin Ahmad, PhD, Hans Peter Schwarz, MD, Friedrich Scheiflinger, PhD, Birgit M Reipert, PhD, Maurus de la Rosa, PhD

Blood (2011) 118 (21): 2188.

https://doi.org/10.1182/blood.V118.21.2188.2188

Published: 2011

Journal Articles

Induction and Break of Immune Tolerance to Human FVIII in a HLA-DRB1*1501 Humanized Hemophilic Mouse Model

Katharina Nora Steinitz, PhD, Brigitte Binder, Christian Lubich, Rafi Uddin Ahmad, PhD, Markus Weiller, PhD, Maurus de la Rosa, PhD, Hans Peter Schwarz, MD, Friedrich Scheiflinger, PhD, Birgit M Reipert, PhD

Blood (2011) 118 (21): 2280.

https://doi.org/10.1182/blood.V118.21.2280.2280

Published: 2011

Journal Articles

Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model

Pauline M. van Helden, Sabine Unterthurner, Corinna Hermann, Maria Schuster, Rafi U. Ahmad, Alexandra N. Schiviz, Markus Weiller, Gerhard Antoine, Peter L. Turecek, Eva M. Muchitsch, Hans Peter Schwarz, Birgit M. Reipert

Blood (2011) 118 (13): 3698–3707.

https://doi.org/10.1182/blood-2010-11-316521

Published: 2011

Journal Articles

T cell–independent restimulation of FVIII-specific murine memory B cells is facilitated by dendritic cells together with toll-like receptor 7 agonist

Aniko G. Pordes, Christina K. Baumgartner, Peter Allacher, Rafi U. Ahmad, Markus Weiller, Alexandra N. Schiviz, Hans Peter Schwarz, Birgit M. Reipert

Blood (2011) 118 (11): 3154–3162.

https://doi.org/10.1182/blood-2011-02-336198

Published: 2011

NARROW

Evaluation of the Human Factor IX Gene Therapy Vector TAK-748 in Hemophilia: Results from Non-Clinical Studies in Factor IX Knockout Mice and Rhesus Monkeys

AAV8-Specific Immune Adsorption Column: A Treatment Option for Patients with Pre-Existing Anti-AAV8 Neutralizing Antibodies

Influence of Obesity on Factor IX Expression after Gene Therapy in a Mouse Model of Hemophilia B

CD4 + T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice

Preclinical Immunogenicity Assessment of Baxter‘s Longer-Acting FVIII Candidate BAX 855 Using Novel Preclinical Models,

Preclinical Immunogenicity Assessment of Baxter‘s Recombinant Factor VIIa,

Deciphering of CD4 + T Cell Subsets Involved in Maintenance and Break of Immune Tolerance in a Humanized Mouse Model That Is Immune Tolerant to Human FVII

Induction and Break of Immune Tolerance to Human FVIII in a HLA-DRB1*1501 Humanized Hemophilic Mouse Model

Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model

T cell–independent restimulation of FVIII-specific murine memory B cells is facilitated by dendritic cells together with toll-like receptor 7 agonist

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only